NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.

A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats...

Full description

Bibliographic Details
Main Authors: Patricia Sancho, Jèssica Mainez, Eva Crosas-Molist, César Roncero, Conrado M Fernández-Rodriguez, Fernando Pinedo, Heidemarie Huber, Robert Eferl, Wolfgang Mikulits, Isabel Fabregat
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049784/?tool=EBI
id doaj-75617722b61f41f39952517e7d2fb884
record_format Article
spelling doaj-75617722b61f41f39952517e7d2fb8842021-03-04T00:15:43ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0179e4528510.1371/journal.pone.0045285NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.Patricia SanchoJèssica MainezEva Crosas-MolistCésar RonceroConrado M Fernández-RodriguezFernando PinedoHeidemarie HuberRobert EferlWolfgang MikulitsIsabel FabregatA role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2(-/-)/p19(ARF-/-), Stat3(Δhc)/Mdr2(-/-)) and a model of experimental induced fibrosis (CCl(4)) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-β pathway activation. In vitro TGF-β-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-β is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-β-induced epithelial-mesenchymal transition (EMT), but was required for TGF-β-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-β-induced death of hepatocytes.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049784/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Patricia Sancho
Jèssica Mainez
Eva Crosas-Molist
César Roncero
Conrado M Fernández-Rodriguez
Fernando Pinedo
Heidemarie Huber
Robert Eferl
Wolfgang Mikulits
Isabel Fabregat
spellingShingle Patricia Sancho
Jèssica Mainez
Eva Crosas-Molist
César Roncero
Conrado M Fernández-Rodriguez
Fernando Pinedo
Heidemarie Huber
Robert Eferl
Wolfgang Mikulits
Isabel Fabregat
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
PLoS ONE
author_facet Patricia Sancho
Jèssica Mainez
Eva Crosas-Molist
César Roncero
Conrado M Fernández-Rodriguez
Fernando Pinedo
Heidemarie Huber
Robert Eferl
Wolfgang Mikulits
Isabel Fabregat
author_sort Patricia Sancho
title NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
title_short NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
title_full NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
title_fullStr NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
title_full_unstemmed NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
title_sort nadph oxidase nox4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2(-/-)/p19(ARF-/-), Stat3(Δhc)/Mdr2(-/-)) and a model of experimental induced fibrosis (CCl(4)) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-β pathway activation. In vitro TGF-β-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-β is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-β-induced epithelial-mesenchymal transition (EMT), but was required for TGF-β-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-β-induced death of hepatocytes.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049784/?tool=EBI
work_keys_str_mv AT patriciasancho nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT jessicamainez nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT evacrosasmolist nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT cesarroncero nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT conradomfernandezrodriguez nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT fernandopinedo nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT heidemariehuber nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT roberteferl nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT wolfgangmikulits nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
AT isabelfabregat nadphoxidasenox4mediatesstellatecellactivationandhepatocytecelldeathduringliverfibrosisdevelopment
_version_ 1714810444530581504